Abeona Therapeutics EBITDA 2010-2022 | ABEO

Abeona Therapeutics ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Abeona Therapeutics Annual EBITDA
(Millions of US $)
2021 $-85
2020 $-76
2019 $-69
2018 $-56
2017 $-27
2016 $-23
2015 $-18
2014 $-3
2013 $-4
2012 $-4
2011 $-8
2010 $-8
2009 $-9
Abeona Therapeutics Quarterly EBITDA
(Millions of US $)
2022-03-31 $-19
2021-12-31 $-48
2021-09-30 $-14
2021-06-30 $-13
2021-03-31 $-14
2020-12-31 $-13
2020-09-30 $-5
2020-06-30 $-11
2020-03-31 $-46
2019-12-31 $-14
2019-09-30 $-16
2019-06-30 $-22
2019-03-31 $-17
2018-12-31 $-17
2018-09-30 $-16
2018-06-30 $-12
2018-03-31 $-11
2017-12-31 $-9
2017-09-30 $-5
2017-06-30 $-8
2017-03-31 $-5
2016-12-31 $-6
2016-09-30 $-5
2016-06-30 $-7
2016-03-31 $-6
2015-12-31 $-6
2015-09-30 $-6
2015-06-30 $-4
2015-03-31 $-2
2014-12-31 $-2
2014-09-30 $1
2014-06-30 $-1
2014-03-31 $-1
2013-12-31 $-1
2013-09-30 $-1
2013-06-30 $-2
2013-03-31 $-1
2012-12-31 $-1
2012-09-30 $-1
2012-06-30 $-1
2012-03-31 $-1
2011-12-31 $-2
2011-09-30 $-2
2011-06-30 $-2
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-2
2010-06-30 $-2
2010-03-31 $-2
2009-12-31 $-2
2009-09-30 $-4
2009-06-30 $-2
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.022B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $164.215B 9.99
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.343B 16.33
Biohaven Pharmaceutical Holding (BHVN) United States $10.057B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.540B 0.00
Emergent Biosolutions (EBS) United States $1.675B 7.17
Arcus Biosciences (RCUS) United States $1.287B 32.64
Myovant Sciences (MYOV) United Kingdom $0.927B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.347B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.113B 23.10
SQZ Biotechnologies (SQZ) United States $0.094B 0.00